1.48
price up icon1.37%   0.02
after-market Handel nachbörslich: 1.50 0.02 +1.35%
loading

Novabay Pharmaceuticals Inc Aktie (NBY) Neueste Nachrichten

pulisher
Mar 04, 2026

NBY Earnings History & Surprises | EPS & Revenue Results | NOVABAY PHARMACEUTICALS INC (NYSEARCA:NBY) - ChartMill

Mar 04, 2026
pulisher
Mar 03, 2026

Breakouts Watch: What are the risks of holding NovaBay Pharmaceuticals IncPortfolio Growth Summary & Weekly Market Pulse Updates - baoquankhu1.vn

Mar 03, 2026
pulisher
Mar 02, 2026

Gross margin % of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Mar 02, 2026
pulisher
Feb 28, 2026

NBY SEC FilingsNovabay Pharma 10-K, 10-Q, 8-K Forms - Stock Titan

Feb 28, 2026
pulisher
Feb 26, 2026

Net current asset value per share of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

NovaBay Pharmaceuticals, Inc. Earnings and Revenue – GETTEX:B9P1 - TradingView

Feb 26, 2026
pulisher
Feb 25, 2026

Cash per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Passes Below 50-Day Moving AverageHere's What Happened - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Diluted net income available to common stockholders of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Debt to assets ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Tangible book value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Net current asset value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Enterprise value to EBITDA ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Free cash flow per share of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Operating income of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Price to cash flow ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Diluted shares outstanding of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total revenue of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Free cash flow of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Enterprise value of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Operating expenses (excl. COGS) of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Number of employees of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Gross margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Operating margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Return on invested capital % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Diluted earnings per share (diluted EPS) of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

EBITDA of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Free cash flow per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

EBITDA per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total liabilities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Debt to equity ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Cash from operating activities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Long term debt to total equity ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals, Inc. Earnings and Revenue – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

EBIT of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Operating income of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Average basic shares outstanding of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total operating expenses of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Net debt of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total liabilities & shareholders' equities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Cost of goods sold of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total equity of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Quick ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals, Inc. Cash Flow – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals, Inc. Income Statement – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total debt per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Net margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals, Inc. Balance Sheet – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 24, 2026

Diluted earnings per share (diluted EPS) of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

NovaBay Pharmaceuticals, Inc. Financial Statements – MUN:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

NovaBay Pharmaceuticals, Inc. Dividends – MUN:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

CapEx per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Gross profit of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Price to book ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Inventory turnover of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

EBITDA of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Dilution adjustment of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

NovaBay Pharmaceuticals, Inc. Statistics – FWB:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Preferred dividends of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Net income before discontinued operations of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

EBIT of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Net income of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Total revenue of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Book value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Asset turnover of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

EBIT of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Price to sales ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Current ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

EBITDA margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Basic earnings per share (basic EPS) of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Total common shares outstanding of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

NovaBay Pharmaceuticals, Inc. Statistics – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Free cash flow of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Diluted shares outstanding of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Non-controlling/minority interest of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Total debt of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
Kapitalisierung:     |  Volumen (24h):